Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia： Results of the Fi

John C. ByrdStock and Other Ownership Interests: Vincerx PharmaHonoraria: Pharmacyclics, AstraZeneca, Novartis, Syndax, Trillium TherapeuticsConsulting or Advisory Role: Acerta Pharma, Janssen, Kura Oncology, Novartis, Syndax, AstraZenecaResearch Funding: Acerta Pharma, Pharmacyclics, ZencorPatents, Royalties, Other Intellectual Property: OSU PatentsTravel, Accommodations, Expenses: Gilead Sciences, Janssen, Novartis, Pharmacyclics, TG Therapeutics Peter HillmenHonoraria: Janssen, AbbVie, RocheResearch Funding: Janssen, Pharmacyclics, Roche, Gilead Sciences, AbbVieTravel, Accommodations, Expenses: Janssen, AbbVie Paolo GhiaHonoraria: AbbVie, BeiGene, Janssen Oncology, Gilead Sciences, Juno Therapeutics, Sunesis Pharmaceuticals, ArQule, Adaptive Biotechnologies, Dynamo Therapeutics, MEI Pharma, Acerta Pharma/AstraZeneca, Juno/Celgene/Bristol Myers Squibb, MSD, Lilly, RocheConsulting or Advisory Role: AbbVie, BeiGene, Janssen, Gilead Sciences, Sunesis Pharmaceuticals, Juno Therapeutics, ArQule, Adaptive Biotechnologies, Dynamo Therapeutics, MEI Pharma, Acerta Pharma/AstraZeneca, MSD, Lilly, RocheResearch Funding: AbbVie, Janssen Oncology, Gilead Sciences, Sunesis Pharmaceuticals, Novartis, AstraZeneca Arnon P. KaterConsulting or Advisory Role: Janssen Oncology, AbbVie/Genentech, AstraZeneca, Bristol Myers Squibb/Celgene, Lava TherapeuticsResearch Funding: Janssen Oncology, Roche/Genentech, Bristol Myers Squibb/Celgene, AbbVie, AstraZenecaTravel, Accommodations, Expenses: Acerta Pharma/AstraZeneca, Roche/Genentech Asher Chanan-KhanStock and Other Ownership Interests: Matthew & Asher Inc, NanoDev Therapeutics, STARTON TherapeuticsHonoraria: BeiGene, Ascentage PharmaResearch Funding: Ascentage PharmaPatents, Royalties, Other Intellectual Property: Patent on PSMB9 biomarker Richard R. FurmanHonoraria: Janssen, AstraZenecaConsulting or Advisory Role: Pharmacyclics, Janssen Biotech, Genentech/Roche, Loxo, TG Therapeutics, Verastem, Acerta Pharma, AstraZeneca, Beigene, Incyte, OncoTracker, AbbVie, MorphoSys, SanofiResearch Funding: Acerta Pharma, TG TherapeuticsExpert Testimony: AbbVie, Janssen OncologyTravel, Accommodations, Expenses: TG Therapeutics, Janssen OncologyOther Relationship: Incyte, Janssen Biotech Susan O'BrienEmployment: University of California, IrvineHonoraria: Celgene, Janssen, Pharmacyclics, Gilead Sciences, Pfizer, Amgen, Astellas Pharma, GlaxoSmithKline, Aptose Biosciences, Vaniam Group, AbbVie, Sunesis Pharmaceuticals, Alexion Pharmaceuticals, Eisai, TG Therapeutics, Nova Research CompanyConsulting or Advisory Role: Amgen, Celgene, GlaxoSmithKline, Janssen Oncology, Aptose Biosciences, Vaniam Group, AbbVie/Genentech, Sunesis Pharmaceuticals, Alexion Pharmaceuticals, Astellas Pharma, Gilead Sciences, Pharmacyclics, TG Therapeutics, Pfizer, Sunesis PharmaceuticalsResearch Funding: Acerta Pharma, Regeneron, Gilead Sciences, Pfizer, TG Therapeutics, Pharmacyclics, Kite, a Gilead company, Sunesis PharmaceuticalsTravel, Accommodations, Expenses: Celgene, Janssen, Gilead Sciences, Regeneron, Janssen Oncology Mustafa Nuri YenerelConsulting or Advisory Role: Pfizer, Alexion PharmaceuticalsSpeakers' Bureau: Janssen OncologyTravel, Accommodations, Expenses: Pfizer Arpad IllésConsulting or Advisory Role: Janssen, Takeda, Novartis, Pfizer, Roche, CelgeneResearch Funding: Takeda, Seattle GeneticsTravel, Accommodations, Expenses: Novartis, Janssen, Pfizer, Roche Neil KayConsulting or Advisory Role: MorphoSys, Celgene, Agios, CytomX Therapeutics, AstraZeneca, Pharmacyclics, DAVA Pharmaceuticals, Juno Therapeutics, Rigel, Oncotracker, Bristol Myers Squibb, AbbVie, Targeted Oncology, Acerta Pharma/AstraZeneca, MEI Pharma, Sunesis Pharmaceuticals, TG Therapeutics, Tolero Pharmaceuticals, Janssen Biotech, Genentech/AbbVieResearch Funding: Pharmacyclics/Janssen, Tolero Pharmaceuticals, Acerta Pharma, MEI Pharma, Celgene, Genentech, Sunesis Pharmaceuticals, AbbVie, TG Therapeutics, Bristol Myers Squibb Jose A. Garcia-MarcoConsulting or Advisory Role: AbbVie, Janssen, AstraZeneca SpainSpeakers' Bureau: AbbVie, Janssen, AstraZeneca SpainResearch Funding: AbbVie, JanssenTravel, Accommodations, Expenses: AbbVie, Janssen Anthony MatoConsulting or Advisory Role: TG Therapeutics, AbbVie/Genentech, Celgene, Pharmacyclics, Adaptive Biotechnologies, Verastem, Johnson & Johnson, Acerta Pharma/AstraZeneca, DTRM, Loxo/Lilly, Curio/Vaniam Group, Merck, Bristol Myers Squibb/PfizerResearch Funding: Regeneron, TG Therapeutics, Sunesis Pharmaceuticals, LOXO, AbbVie/Genentech, Pharmacyclics, Adaptive Biotechnologies, Johnson & Johnson, Acerta Pharma/AstraZeneca, DTRM, Genmab, Nurix Javier Pinilla-IbarzHonoraria: Novartis, Pharmacyclics, Janssen, AbbVie, Takeda, AstraZenecaConsulting or Advisory Role: Novartis, Pharmacyclics, Janssen, AbbVieSpeakers' Bureau: Pharmacyclics/Janssen, AbbVie, Takeda, AstraZenecaPatents, Royalties, Other Intellectual Property: From a WT vaccine patent by Memorial Sloan Kettering Cancer Center John F. SeymourHonoraria: AbbVie, Acerta Pharma, Janssen, Roche, Sunesis Pharmaceuticals, TakedaConsulting or Advisory Role: AbbVie, Acerta Pharma, Janssen, Roche, Sunesis Pharmaceuticals, Takeda, AstraZeneca, BMS, Gilead Sciences, MEI Pharma, MorphoSysSpeakers' Bureau: AbbVie, RocheResearch Funding: AbbVie, Celgene, Janssen, RocheExpert Testimony: RocheTravel, Accommodations, Expenses: AbbVie, Roche Stephan StilgenbauerHonoraria: AbbVie, AstraZeneca, Celgene, Gilead Sciences, GlaxoSmithKline, Roche, JanssenConsulting or Advisory Role: AbbVie, AstraZeneca, Celgene, Gilead Sciences, GlaxoSmithKline, Roche, JanssenSpeakers' Bureau: AbbVie, AstraZeneca, Celgene, Gilead Sciences, GlaxoSmithKline, Roche, JanssenResearch Funding: AbbVie, AstraZeneca, Celgene, Gilead Sciences, GlaxoSmithKline, Roche, JanssenTravel, Accommodations, Expenses: AbbVie, AstraZeneca, Celgene, Gilead Sciences, GlaxoSmithKline, Roche, Janssen Tadeusz RobakHonoraria: AbbVieConsulting or Advisory Role: AbbVieResearch Funding: AbbVie/Genentech Wayne RothbaumLeadership: Iovance BiotherapeuticsStock and Other Ownership Interests: Acerta Pharma/AstraZeneca, Telios, Kartos TherapeuticsPatents, Royalties, Other Intellectual Property: Telios Pharma and Kartos TherapeuticsTravel, Accommodations, Expenses: Iovance Biotherapeutics, Kartos TherapeuticsUncompensated Relationships: Kartos Therapeutics, Telios Raquel IzumiEmployment: Acerta Pharma, Vincerx PharmaStock and Other Ownership Interests: Acerta Pharma, Vincerx PharmaPatents, Royalties, Other Intellectual Property: Patents pending for Acerta PharmaExpert Testimony: Diablo Valley Oncology Ahmed HamdyEmployment: Acerta Pharma/AstraZenecaStock and Other Ownership Interests: Acerta PharmaPatents, Royalties, Other Intellectual Property: Acalabrutinib multiple patents Priti PatelEmployment: AstraZeneca, Neoleukin TherapeuticsLeadership: Neoleukin TherapeuticsStock and Other Ownership Interests: AstraZeneca, Neoleukin Therapeutics Kara HigginsEmployment: AstraZeneca, PROMETRIKA LLC Sophia SohoniEmployment: AstraZeneca, Portola PharmaceuticalsStock and Other Ownership Interests: Theravance Wojciech JurczakConsulting or Advisory Role: Janssen-Cilag, Roche, AstraZeneca, Debiopharm Group, EpizymeResearch Funding: Acerta Pharma, TG Therapeutics, Incyte, Bayer, Sandoz-Novartis, Roche, Takeda, Epizyme, Janssen-Cilag, BeiGene, Debiopharm Group, MorphoSys, MEI PharmaNo other potential conflicts of interest were reported.